Biggest prostate cancer screening trial in decades begins in UK

A new £42 million prostate cancer screening trial, the Transform study, has been launched in the UK to improve early detection of the disease. Men aged 50-74, with a lower age limit of 45 for black men, are being invited to participate in this major study, which aims to combine rapid MRI scans with PSA blood tests for more accurate cancer diagnosis. With testimonies like Danny Burkey's advocating for earlier screening to prevent unnecessary harm and save lives, the trial is expected to significantly impact prostate cancer diagnosis and treatment in the UK.